Cargando…

Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer's Disease or Mild Cognitive Impairment

OBJECTIVES: Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most common form of dementia in the elderly. Certain genes have been identified as important clinical risk factors for AD, and technological advances in genomic research, such as genome-wide associatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lanlan, Yang, Yeying, Zhang, Qi, Wang, Jiao, Jiang, Jiehui, Neuroimaging Initiative, Alzheimer's Disease
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298161/ https://www.ncbi.nlm.nih.gov/pubmed/34336000 http://dx.doi.org/10.1155/2021/3359103

Ejemplares similares

Structural Brain Imaging Phenotypes of Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) Found by Hierarchical Clustering
por: Kärkkäinen, Mikko, et al.
Publicado: (2020)

Multimodal MRI-based imputation of the Aβ+ in early mild cognitive impairment
por: Tosun, Duygu, et al.
Publicado: (2014)

Topological Measurements of DWI Tractography for Alzheimer's Disease Detection
por: Amoroso, Nicola, et al.
Publicado: (2017)

Classification of Alzheimer's and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET
por: Nozadi, Seyed Hossein, et al.
Publicado: (2018)

Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study
por: Swaminathan, Shanker, et al.
Publicado: (2011)

Protective Factors Modulate the Risk of Beta Amyloid in Alzheimer's Disease
por: Zhou, Bin, et al.
Publicado: (2020)

Study of the Influence of Age in (18)F-FDG PET Images Using a Data-Driven Approach and Its Evaluation in Alzheimer's Disease
por: Jiang, Jiehui, et al.
Publicado: (2018)

Applications of Neuroimaging to Disease-Modification Trials in Alzheimer’s Disease
por: Fleisher, Adam S., et al.
Publicado: (2009)

A Real-Time Clinical Decision Support System, for Mild Cognitive Impairment Detection, Based on a Hybrid Neural Architecture
por: Suárez-Araujo, Carmen Paz, et al.
Publicado: (2021)

Identifying the Alteration Patterns of Brain Functional Connectivity in Progressive Mild Cognitive Impairment Patients: A Longitudinal Whole-Brain Voxel-Wise Degree Analysis
por: Deng, Yanjia, et al.
Publicado: (2016)

Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
por: De Velasco Oriol, Javier, et al.
Publicado: (2019)

Functional Evolving Patterns of Cortical Networks in Progression of Alzheimer's Disease: A Graph-Based Resting-State fMRI Study
por: Li, Wei, et al.
Publicado: (2020)

The Combination of Functional and Structural MRI Is a Potential Screening Tool in Alzheimer’s Disease
por: Huang, Chun-Chao, et al.
Publicado: (2018)

Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease
por: Upadhyaya, Yurika, et al.
Publicado: (2020)

Cloud-Based Brain Magnetic Resonance Image Segmentation and Parcellation System for Individualized Prediction of Cognitive Worsening
por: Sakamoto, Ryo, et al.
Publicado: (2019)

Tissue-Based MRI Intensity Standardization: Application to Multicentric Datasets
por: Robitaille, Nicolas, et al.
Publicado: (2012)

Frequency Specific Effects of ApoE ε4 Allele on Resting-State Networks in Nondemented Elders
por: Liang, Ying, et al.
Publicado: (2017)

Metabolically healthy obesity reduces the risk of Alzheimer’s disease in elders: a longitudinal study
por: Ma, Ling-Zhi, et al.
Publicado: (2019)

CSF-Targeted Proteomics Indicate Amyloid-Beta Ratios in Patients with Alzheimer's Dementia Spectrum
por: Behzad, Maryam, et al.
Publicado: (2023)

Standardized quality metric system for structural brain magnetic resonance images in multi-center neuroimaging study
por: Osadebey, Michael E., et al.
Publicado: (2018)

Journey to the other side of the brain: asymmetry in patients with chronic mild or moderate traumatic brain injury
por: Ross, David E, et al.
Publicado: (2023)

A Comprehensive Investigation of the Potential Role of Lipoproteins and Metabolite Profile as Biomarkers of Alzheimer's Disease Compared to the Known CSF Biomarkers
por: Nasab, Azam Sajjadi, et al.
Publicado: (2023)

Comparison of nine tractography algorithms for detecting abnormal structural brain networks in Alzheimer’s disease
por: Zhan, Liang, et al.
Publicado: (2015)

Late-life obesity is a protective factor for prodromal Alzheimer’s disease: a longitudinal study
por: Sun, Zhen, et al.
Publicado: (2020)

Structural Neuroimaging in the Detection and Prognosis of Pre-Clinical and Early AD
por: Fennema-Notestine, Christine, et al.
Publicado: (2009)

Plasma sex hormone-binding globulin predicts neurodegeneration and clinical progression in prodromal Alzheimer's disease
por: Xu, Wei, et al.
Publicado: (2020)

The Memory Alteration Test Discriminates between Cognitively Healthy Status, Mild Cognitive Impairment and Alzheimer's Disease
por: Custodio, Nilton, et al.
Publicado: (2014)

Based on Tau PET Radiomics Analysis for the Classification of Alzheimer’s Disease and Mild Cognitive Impairment
por: Jiao, Fangyang, et al.
Publicado: (2023)

Generative adversarial network constrained multiple loss autoencoder: A deep learning‐based individual atrophy detection for Alzheimer's disease and mild cognitive impairment
por: Shi, Rong, et al.
Publicado: (2022)

Classification of Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Unimpaired Individuals Using Multi-feature Kernel Discriminant Dictionary Learning
por: Li, Qing, et al.
Publicado: (2018)

Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images
por: Shen, Ting, et al.
Publicado: (2019)

In Search of Sleep Biomarkers of Alzheimer’s Disease: K-Complexes Do Not Discriminate between Patients with Mild Cognitive Impairment and Healthy Controls
por: Reda, Flaminia, et al.
Publicado: (2017)

Discrimination between Alzheimer's Disease and Mild Cognitive Impairment Using SOM and PSO-SVM
por: Yang, Shih-Ting, et al.
Publicado: (2013)

Development of a Machine Learning Model to Discriminate Mild Cognitive Impairment Subjects from Normal Controls in Community Screening
por: Jiang, Juanjuan, et al.
Publicado: (2022)

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease
por: Zhou, Hucheng, et al.
Publicado: (2019)

Emotional Processing in Healthy Ageing, Mild Cognitive Impairment, and Alzheimer’s Disease
por: Cárdenas, José, et al.
Publicado: (2021)

Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline
por: Bauer, Corinna M., et al.
Publicado: (2018)

Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer’s Disease
por: Jääskeläinen, Olli, et al.
Publicado: (2020)

Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment
por: Christensen, Kurt D., et al.
Publicado: (2020)

Relationship of sex differences in cortical thickness and memory among cognitively healthy subjects and individuals with mild cognitive impairment and Alzheimer disease
por: Cieri, Filippo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2ibc7j8jr675jakmmv86re1igg